##gff-version 3
##sequence-region Q14957 1 1233
Q14957	UniProtKB	Signal peptide	1	19	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14957	UniProtKB	Chain	20	1233	.	.	.	ID=PRO_0000011580;Note=Glutamate receptor ionotropic%2C NMDA 2C	
Q14957	UniProtKB	Topological domain	20	554	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Transmembrane	555	573	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Topological domain	574	600	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Intramembrane	601	620	.	.	.	Note=Discontinuously helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Topological domain	621	627	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Transmembrane	628	643	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Topological domain	644	814	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Transmembrane	815	834	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Topological domain	835	1233	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Region	509	511	.	.	.	Note=Glutamate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q14957	UniProtKB	Region	601	620	.	.	.	Note=Pore-forming;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Region	687	688	.	.	.	Note=Glutamate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q14957	UniProtKB	Motif	1231	1233	.	.	.	Note=PDZ-binding	
Q14957	UniProtKB	Binding site	511	511	.	.	.	Note=Glutamate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Binding site	516	516	.	.	.	Note=Glutamate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q14957	UniProtKB	Binding site	729	729	.	.	.	Note=Glutamate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00960	
Q14957	UniProtKB	Site	612	612	.	.	.	Note=Functional determinant of NMDA receptors;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14957	UniProtKB	Modified residue	875	875	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q01098	
Q14957	UniProtKB	Modified residue	881	881	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q01098	
Q14957	UniProtKB	Modified residue	912	912	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00961	
Q14957	UniProtKB	Glycosylation	70	70	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14957	UniProtKB	Glycosylation	337	337	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14957	UniProtKB	Glycosylation	438	438	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14957	UniProtKB	Glycosylation	539	539	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q14957	UniProtKB	Disulfide bond	82	317	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q14957	UniProtKB	Disulfide bond	426	453	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q14957	UniProtKB	Disulfide bond	433	454	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q14957	UniProtKB	Disulfide bond	743	798	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q14957	UniProtKB	Natural variant	18	1233	.	.	.	ID=VAR_079958;Note=Found in a patient with autism spectrum disorder%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
Q14957	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_079959;Note=V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs192960268,PMID:22833210	
Q14957	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_079960;Note=A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs201199917,PMID:22833210	
Q14957	UniProtKB	Natural variant	573	573	.	.	.	ID=VAR_079961;Note=M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
Q14957	UniProtKB	Natural variant	641	641	.	.	.	ID=VAR_079962;Note=A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs746610735,PMID:22833210	
Q14957	UniProtKB	Natural variant	679	679	.	.	.	ID=VAR_079963;Note=Found in a patient with schizophrenia%3B unknown pathological significance. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs1381530257,PMID:22833210	
Q14957	UniProtKB	Natural variant	863	863	.	.	.	ID=VAR_079964;Note=Found in a patient with autism spectrum disorder%3B unknown pathological significance. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs1308468356,PMID:22833210	
Q14957	UniProtKB	Natural variant	871	871	.	.	.	ID=VAR_079965;Note=Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs765016248,PMID:22833210	
Q14957	UniProtKB	Natural variant	877	877	.	.	.	ID=VAR_079966;Note=P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs139011774,PMID:22833210	
Q14957	UniProtKB	Natural variant	911	911	.	.	.	ID=VAR_079967;Note=S->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs370546831,PMID:22833210	
Q14957	UniProtKB	Natural variant	982	982	.	.	.	ID=VAR_079968;Note=P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs960726960,PMID:22833210	
Q14957	UniProtKB	Natural variant	989	989	.	.	.	ID=VAR_079969;Note=Found in a patient with schizophrenia%3B unknown pathological significance. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs552196496,PMID:22833210	
Q14957	UniProtKB	Natural variant	995	995	.	.	.	ID=VAR_079970;Note=Found in a patient with schizophrenia%3B unknown pathological significance. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
Q14957	UniProtKB	Natural variant	1079	1079	.	.	.	ID=VAR_079971;Note=H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs889196426,PMID:22833210	
Q14957	UniProtKB	Natural variant	1141	1141	.	.	.	ID=VAR_079972;Note=P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs751640851,PMID:22833210	
Q14957	UniProtKB	Natural variant	1180	1180	.	.	.	ID=VAR_079973;Note=G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs115230539,PMID:22833210	
Q14957	UniProtKB	Natural variant	1196	1196	.	.	.	ID=VAR_079974;Note=T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs143282101,PMID:22833210	
Q14957	UniProtKB	Natural variant	1209	1209	.	.	.	ID=VAR_037634;Note=R->S;Dbxref=dbSNP:rs3744215	
Q14957	UniProtKB	Mutagenesis	550	550	.	.	.	Note=Changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28095420;Dbxref=PMID:28095420	
Q14957	UniProtKB	Sequence conflict	1048	1048	.	.	.	Note=E->EPPE;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q14957	UniProtKB	Sequence conflict	1057	1057	.	.	.	Note=P->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
